Evidence map›Paper›PMID 29444667›Full record

ArticleBMC complementary and alternative medicine2018

In vitro antileishmanial and cytotoxicity activities of essential oils from Haplophyllum tuberculatum A. Juss leaves, stems and aerial parts.

Assia Hamdi, Joanne Bero, Claire Beaufay, Guido Flamini, Zohra Marzouk, Yvan Vander Heyden, Joelle Quetin-Leclercq

Open access · goldAbstract read
In one paragraph

Article in BMC complementary and alternative medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Chemical Composition and Insecticidal, Antiplasmodial, and Anti-Leishmanial Activity ofEvidence-based complementary and alternative medicine : eCAM · 2022
    Article
  8. Lignans, Amides, and Saponins fromMolecules (Basel, Switzerland) · 2020
    Article
  9. Article
  10. Molecules (Basel, Switzerland) · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Assia HamdiDepartment of Analytical Chemistry, Applied Chemometrics and Molecular Modelling (FABI), Center for Pharmaceutical Research (CePhaR), Vrije Universiteit Brussel (VUB), Laarbeeklaan 103, 1090, Brussels, Belgium. hamdiessia@gmail.com.
Joanne BeroPharmacognosy Research Group (GNOS), Louvain Drug Research Institute (LDRI), Université catholique de Louvain (UCL), B1.72.03 Av. E. Mounier 72, B-1200, Bruxelles, Belgium.
Claire BeaufayPharmacognosy Research Group (GNOS), Louvain Drug Research Institute (LDRI), Université catholique de Louvain (UCL), B1.72.03 Av. E. Mounier 72, B-1200, Bruxelles, Belgium.
Guido FlaminiDipartimento di Scienze Farmaceutiche, Sede Chimica Bioorganica e Biofarmacia, Università di Pisa, Via Bonanno 33, 56126, Pisa, Italy.
Zohra MarzoukLaboratoire de Développement Chimique Galénique et Pharmacologique des Médicaments. Faculté de Pharmacie, Université de Monastir, 5000, Monastir, Tunisia.
Yvan Vander HeydenDepartment of Analytical Chemistry, Applied Chemometrics and Molecular Modelling (FABI), Center for Pharmaceutical Research (CePhaR), Vrije Universiteit Brussel (VUB), Laarbeeklaan 103, 1090, Brussels, Belgium. Yvan.Vander.Heyden@vub.be.
Joelle Quetin-LeclercqPharmacognosy Research Group (GNOS), Louvain Drug Research Institute (LDRI), Université catholique de Louvain (UCL), B1.72.03 Av. E. Mounier 72, B-1200, Bruxelles, Belgium.
UCLouvain · BEUniversity of Monastir · TNUniversity of Pisa · ITVrije Universiteit Brussel · BE

Funding

Belgian Fund of Scientific Research (FNRS) T.0190.13
6 · The paper itself

Abstract

backgroundPlants used for traditional medicine produce diverse and complex secondary metabolites exhibiting various medicinal properties. The medicinal plant Haplophyllum tuberculatum is used by native people against malaria and parasitic infections.

methodsIn this study and in order to contribute for the search of new natural drugs for leishmaniasis, the essential oils of H. tuberculatum leaves, stems and aerial parts (leaves+stems) collected in two different periods, 2013 and 2015, and their components by GC/FID and GC/MS analyses were investigated. Those collected in 2013 were also re-analyzed two years later. The extracted oils were screened in vitro for anti-leishmanial activity on Leishmania mexicana mexicana (L.m.m.) promastigotes and cytotoxicity on the Chinese Hamster Ovary (CHO) cell line. Limonene (1.5 - 8%), its isomers (R- (+)-limonene and S-(-)-limonene), linalool and octanol were also tested.

resultsResults showed that the chemical composition varied according to the year of collection. Though major compounds remain almost the same, qualitative and quantitative variations in the composition of the EOs can be observed between the two years of collection, with some minor compounds identified only in one type of samples. Variation in the composition were also observed in the re-analyzed volatile oils, showing stability concerns. The essential oils and R-(+)-limonene showed moderate anti-leishmanial activity. Their IC

conclusionsThe findings of the present study demonstrated that H. tuberculatum might not be considered as a natural source for production of new anti-leishmanial agents without further analyzing its eventual in vivo toxicity as well as that of major pure compounds.

Indexed as

AnimalsAntiprotozoal AgentsCHO CellsCricetinaeCricetulusGas Chromatography-Mass SpectrometryHumansLeishmania mexicanaLeishmaniasis, CutaneousOils, VolatilePlant ExtractsPlant LeavesPlant OilsPlant StemsRutaceaeAntiprotozoal AgentsOils, VolatilePlant ExtractsPlant OilsAnti-leishmanialCytotoxicityEssential oilsHaplophyllum tuberculatumLimonene

Identifiers

PMID29444667
PMCPMC5813356
OpenAlexW2804577919

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.